XRAY
47
-2
FLR
46
-2
XEL
53
-2
SBUX
32
-9
MAS
52
-2
O
19
-12
FCX
50
-2
PNR
66
-3
KR
57
-6
KHC
22
2
UHS
52
2
STX
42
-2
PRU
45
-2
PSA
48
-2
CA
25
-7
FMC
37
-2
AIZ
66
-2
VZ
39
2
ALL
41
6
TGNA
50
-3
XRAY
47
-2
FLR
46
-2
XEL
53
-2
SBUX
32
-9
MAS
52
-2
O
19
-12
FCX
50
-2
PNR
66
-3
KR
57
-6
KHC
22
2
UHS
52
2
STX
42
-2
PRU
45
-2
PSA
48
-2
CA
25
-7
FMC
37
-2
AIZ
66
-2
VZ
39
2
ALL
41
6
TGNA
50
-3
Financhill
Back

Palatin Technologies Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
40

PTN
Palatin Technologies

Last Price:
0.88
Seasonality Move:
6.65%
Sell
23

NBY
NovaBay Pharmaceuticals

Last Price:
0.58
Seasonality Move:
-6.51%
Sell
40
Palatin Technologies (PTN) is a Sell

Is Palatin Technologies a Buy, Sell or Hold?

  • The current Palatin Technologies [PTN] share price is $0.88. The Score for PTN is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • PTN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.57. The Score for NBY is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PTN Stock Price Chart

What is Palatin Technologies's stock price today?

  • The Palatin Technologies share price today is $0.88
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PTN is experiencing buying pressure, which is a positive indicator for future bullish movement.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.57
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing slight buying pressure.

PTN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.05 Sell
Relative Strength Index (14 RSI): 38.72 Sell
Chaikin Money Flow: 174691 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.9 - 1.14) Sell
Bollinger Bands (100): (0.94 - 1.48) Sell

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 41.63 Sell
Chaikin Money Flow: 40319 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.57 - 0.71) Sell
Bollinger Bands (100): (0.4 - 0.86) Sell

PTN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.91 Sell
20-day SMA: 0.98 Sell
50-day SMA: 1.03 Sell
200-day SMA: 1.54 Sell
8-day EMA: 0.92 Sell
20-day EMA: 0.98 Sell
50-day EMA: 1.07 Sell
200-day EMA: 1.56 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.57 Buy
20-day SMA: 0.62 Sell
50-day SMA: 0.65 Sell
200-day SMA: 2 Sell
8-day EMA: 0.58 Sell
20-day EMA: 0.61 Sell
50-day EMA: 0.67 Sell
200-day EMA: 4.92 Sell

Palatin Technologies Earnings Growth & PTN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.39 per share, and an increase next year of $0.85 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.

Palatin Technologies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):